Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2022 Sep 23;13:972477. doi: 10.3389/fphar.2022.972477

Corrigendum: Insulin treatment of hypertriglyceridemia during pregnancy

De-cui Cheng 1, Yao Su 1, Feifei Li 1, Xianming Xu 1,*
PMCID: PMC9539834  PMID: 36210840

In the published article, there was an error in the Affiliation. Instead of “Department of Obstetrics and Gynecology, Jiao Tong University School of Medicine, Shanghai, China,” it should be “Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai, China.”

Additionally, a correction has been made to Methods section, paragraph 1. The last sentence previously stated “This research was registered with the Chinese Clinical Trial Registry (ChiCTR2000036575).” However the correct sentence is “This research was funded by the Chinese Clinical Trial Registry (ChiCTR2000036575).” The Conflict of Interest statement has also been updated to reflect this.

The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.

Conflict of interest

This study received funding from Chinese Clinical Trial Registry (ChiCTR2000036575). The funder had the following involvement with the study: service charge of postgraduates collecting data and also for publishing fee.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES